HIGHLIGHTS
- who: BioMed Central from the of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK have published the research: Bio Med Central, in the Journal: (JOURNAL) of 22/Oct/2002
- what: The WISDOM trial was designed to compare combined estrogen and progestogen versus placebo and estrogen alone versus combined estrogen and progestogen. The authors submitted a business case for the trial showing that as long as the trial gave a clear answer to the question of balance of risks and benefits costs were justified. The aim of the WISDOM . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.